银杏达莫注射液与复方丹参注射液治疗脑梗死临床疗效对比分析

目的观察银杏达莫注射液与复方丹参注射液治疗急性脑梗死(ACI)的临床疗效。方法随机将120例急性脑梗死患者分为两组,银杏达莫组(观察组)60例,复方丹参注射液组(对照组)60例。观察组:银杏达莫注射液20ml+0.9%生理盐水250ml静滴,1次/d;对照组:复方丹参注射液20ml+0.9%生理盐水250ml静滴,1次/d。疗程均为15d。结果观察组、对照组的总有效率分别为85%、63.3%,两组比较,P<0.01。结论银杏达莫在急性脑梗死治疗中优于复方丹参注射液,疗效确切。

Objective To observe the Ginkgo biloba extract and dipyridamole injection and compound Salvia injection in treating acute cerebral infarction （ACI） of the clinical efficacy. Methods 120 cases were randomly divided into two groups in patients with acute cerebral infarction, gingko and dipyridamole group （observation group） 60 cases of compound Danshen injection group （control group） 60 cases. Observer Group： Ginkgo biloba extract and dipyridamole injection 20ml ＋ 0.9% normal saline intravenous infusion of 250ml, 1 / d; control group： compound Danshen injection 20ml ＋0.9% saline infusion 250ml, 1 / d. Treatment were 15d. Results The control group the total effective rate were 85%, 63.3%, the two groups, P 〈0.01. Conclusion Yinxingdamo the treatment of acute cerebral infarction is better than compound Danshen injection, the exact effect.